Should you buy Nestle India, Tech Mahindra, Indus Towers, Ashok Leyland, Laurus Labs, other stocks today? Here is what brokerages suggest

Here's what Goldman Sachs, Jefferies, Macquarie, JPMorgan, Citi, Morgan Stanley, CLSA, HSBC and Nomura make of stocks such as Nestle India (NESTLEIND), Tech Mahindra (TECHM), Indus Towers (INDUSTOWER), Ashok Leyland (ASHOKLEY), Laurus Labs (LAURUSLABS):

Morgan Stanley has an 'equal-weight' rating on Tech Mahindra shares with a target of Rs 1,600. 

Jefferies has maintained an 'underperform' rating on Tech Mahindra shares with a target of Rs 1,300, while JP Morgan has an 'underweight' rating on the stock with a target of Rs 1,300. Meanwhile, Bernstein has maintained an 'outperform' rating with a target of Rs 1,390.

Two brokerages, Goldman Sachs and Citi have maintained a 'sell' call on the Tech Mahindra stock with targets of Rs 1,180 and Rs 1,260, respectively. While Nomura, on the other side, has maintained a 'buy' call on the stock with a target of Rs 1,600.

Both Jefferies and HSBC have maintained a 'hold' call on Nestle India shares with targets of Rs 2,450 and Rs 2,500, respectively, while Citi has maintained a 'buy' call on the stock with a target of Rs 2,900. Meanwhile, Macquarie has maintained a 'neutral' rating with a target of Rs 2,675.
 
Morgan Stanley has maintained an 'underweight' rating on Nestle shares with a target of Rs 2,066. While JPMorgan has maintained an 'overweight' rating on the stock with a target of Rs 2,700. Moreover, CLSA has maintained an 'outperform' rating on with a target of Rs 2,700.

Citi has maintained a 'buy' call on Indus Towers shares with a target of Rs 500.

Macquarie has maintained an 'underperform' rating on the Indus Towers stock with a target of Rs 265.

JPMorgan has maintained an 'overweight' rating on Mankind Pharma shares with a target of Rs 2,390.

UBS has upgraded its rating from 'neutral' to 'buy' on two automobile stocks, Tata Power and Apollo Tyres with targets of Rs 280 and Rs 640, respectively. While, on the other hand, the brokerage has downgraded the rating for Mahindra & Mahindra (M&M) stock to 'neutral' from 'buy' with a target of Rs 3,000.

CLSA has an 'underperform' rating on The Ramco Cements shares with a target of Rs 685, while Citi has maintained a 'sell' call on the stock with a target of Rs 750.

Citi has maintained a 'neutral' rating on AU Small Finance Bank shares with a target of Rs 684.

Morgan Stanley has maintained an 'overweight' rating on AU Bank shares with a target of Rs 850.

Morgan Stanley has an 'underweight' rating on the Cyient stock with a target of Rs 1,550.

Jefferies has maintained a 'buy' call on Mahanagar Gas Ltd (MGL) shares with a target of Rs 1,990.

Jefferies has maintained a 'hold' call on the Ashok Leyland stock with a target of Rs 205, while Macquarie has maintained a 'neutral' rating on the stock with a target of Rs 220. Meanwhile, Nomura has a 'buy' call on the stock with a target of Rs 247.

JPMorgan has maintained an 'overweight' rating on Ashok Leyland shares with a target of Rs 235.

Jefferies has maintained an 'underperform' rating on Laurus Labs shares with a target of Rs 250.

Two brokerages, Goldman Sachs and Citi have maintained a 'sell' call on the Laurus Labs stock with targets of Rs 350 and Rs 320, respectively.

Both Jefferies and Goldman Sachs have maintained a 'buy' call on Syngene International shares with targets of Rs 925 and Rs 925, respectively. Meanwhile, CLSA has maintained an 'underperform' rating on the Syngene stock with a target of Rs 680.

Disclaimer: The views/suggestions/recommendations expressed here in this article are solely by investment experts. Zee Business suggests its readers consult their investment advisers before making any financial decision.